Home » POWER3 MEDICAL CONTINUES PROGRESS ON NUROPRO BLOOD TEST FOR NEURODEGENERATIVE DISEASE DETECTION
POWER3 MEDICAL CONTINUES PROGRESS ON NUROPRO BLOOD TEST FOR NEURODEGENERATIVE DISEASE DETECTION
Power3 Medical Products, a leading proteomics company, announces the completion of the latest stage of clinical validation on the NuroPro, a neurodegenerative disease blood test used as a diagnostic tool in the early stage assessment of ALS and Alzheimer's, Parkinson's, and other diseases.
Yahoo News (http://biz.yahoo.com/pz/050111/70603.html)
KEYWORDS FDAnews Device Daily Bulletin
Upcoming Events
-
18Jul
-
21Oct